Clinicians have proposed a system-wide response plan for the delivery of high-quality palliative care across a continuum of conventional, contingency, and crisis capacity scenarios during the COVID-19 pandemic.
In an address during the American Urological Association’s 2020 Live Virtual Experience, Anthony S. Fauci, MD, a member of the White House Coronavirus Task Force, said the coronavirus pandemic is nowhere near over, but public health measures are making a big difference in reducing the number of cases and related deaths.
Serology tests were better at detecting the presence of antibodies to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in patients when they were tested 15 to 35 days post-symptom onset, according to the findings of a recently published review on the Cochrane Database of Systematic Reviews.
The FDA has granted Fast Track designation to RLF-100 (Aviptadil; NeuroRx and Relief Therapeutics) for the treatment of acute lung injury/acute respiratory distress syndrome associated with coronavirus disease 2019.
A team of investigators conducted a systematic review and meta-analysis to assess whether a shorter-than-recommended duration of antibiotic treatment can be effective for the management of acute uncomplicated cystitis.
The CDC has reported observing a significant increase in the number of meningococcal disease cases with isolates containing a blaROB-1 β-lactamase enzyme gene, conferring resistance to penicillin antibiotics and, in some cases, ciprofloxacin as well.